Clinical Trials Browser

Mouth Neoplasms × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all

NCT01140178 2018-10-16

A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx

Phase 1 Completed

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00670397 2016-03-16

Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer

Phase 1 Terminated

Head and Neck Neoplasms, Mouth Neoplasms